Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Lumos Diagnostics.
RELATED STOCKHEAD STORIES
News
In Case You Missed It: Gold, uranium and a sudden leadership spill are driving the news today
News
In Case You Missed It: Iron ore, oil fields and medical diagnostics deals
Health & Biotech
ASX Health Stocks: Lumos, Singular, and Imricor all jump today after deals and approvals
Health & Biotech
Check Up: What is the FDA emergency use authorisation, and which ASX stocks were given approval?
Health & Biotech
ASX Health Stocks: Lumos granted US FDA emergency-use approval for virus test kit, ViraDx
Health & Biotech
ASX Biotech August Winners: Sector down despite CSL and Cochlear’s strong results, but don’t panic…
Health & Biotech
Check Up: Australian biotech sector continues to be a magnet for US investors
Health & Biotech
Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money will go
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: Tech woes and China combine to drag local markets down 1.5pc
News
In Case You Missed It: Lithium leads but health tech is hot on its heels
News
ASX Small Caps Lunch Wrap: What fresh horror from the deep has science delivered today?
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: Local markets close 0.24pc lower, The Star gets a lifeline and Allkem neighbour Rubix flies high
Health & Biotech
ASX Biotech Winners in July: Down but far from out, here’s why biotechs could stage a comeback
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech